Inhibikase Therapeutics Inc
Ownership
Ownership Structure
Who owns Inhibikase Therapeutics Inc (IKT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.8% of the shares are freely tradable; institutional investors hold 93.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Sands Capital Ventures, LLC | 9.33 | 13,018,965 | +0.0 | 06/30/2026 |
| Soleus Capital Management, L.P. | 7.79 | 10,875,000 | +0.0 | 06/30/2026 |
| Trails Edge Capital Partners, LP | 6.49 | 9,051,318 | +12.3 | 06/30/2026 |
| Fairmount Funds Management LLC | 6.18 | 8,625,000 | +0.0 | 03/31/2026 |
| ADAR1 Capital Management LLC | 4.73 | 6,606,572 | -18.1 | 03/31/2026 |
| Kalehua Capital Management LLC | 4.65 | 6,494,498 | +271.1 | 03/31/2026 |
| BlackRock Inc | 4.52 | 6,303,433 | +90.7 | 03/31/2026 |
| Blackstone Inc | 4.26 | 5,938,276 | +0.0 | 03/31/2026 |
| Siren, L.L.C. | 4.19 | 5,850,000 | +0.0 | 03/31/2026 |
| COMMODORE CAPITAL LP | 3.87 | 5,397,488 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Ra Capital Management, L.p. | 10% Owner | 6,970,000 | 16,031,000 $ | Jul 29, 2026 | indirect |
| Berman Dennis N | Director | 21,854 | 50,264 $ | Jul 30, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Berman Dennis N | Director | Other | 21,854 | 1.26 | 27,536 |
| Jul 29, 2026 | Ra Capital Management, L.p. | 10% Owner | Other | 18,030,000 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.